Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Jason M. Jerry, MD, FAPA maintains an active practice as an addiction psychiatrist at the Cleveland Clinic’s Alcohol and Drug Recovery Center. Dr. Jerry is an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine where he has been very active in medical student and resident education. He has practiced in the field of addictions for over ten years and previously served as the Corporate Medical Director of one of the largest privately owned addiction treatment centers in Florida. He maintains a very active addiction medicine practice where he is involved in inpatient detoxification, the oversight of an intensive outpatient program, and outpatient work with a wide variety of patients including professional athletes. He has been interviewed by several national media groups about addiction-related issues including ABC, NBC, Yahoo News, Good Morning America, The New York Times, The Huffington Post, and Oprah Winfrey. He has authored several articles related to addictions and psychiatric treatment and lectures on a wide array of topics related to substance use disorders. He currently serves as serve as the Chair of the Treatment Subcommittee for the U.S. Attorney’s Heroin and Opioid Action Plan working group, he is a member of the Ohio State Medical Association’s Focused Task Force on State Legislation, and he serves as Chair of the Addiction and Pain Committee for the Ohio Psychiatric Physicians Association. Dr. Jerry is married and has two young children.
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/17/2015, Dr. Jerry has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.